Price T Rowe Associates Inc Rapt Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,028,166 shares of RAPT stock, worth $8.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,028,166

Previous 3,413,552 40.58%

Holding current value

$8.13 Million

Previous $84.8 Million 78.53%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.87 - $26.45 $9.52 Million - $36.6 Million	-1,385,386 Reduced 40.58%	2,028,166 $18.2 Million
Q4 2023 Feb 14, 2024	SELL	$11.28 - $25.46 $1.42 Million - $3.22 Million	-126,289 Reduced 3.57%	3,413,552 $84.8 Million
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $851,117 - $1.28 Million	52,088 Added 1.49%	3,539,841 $58.8 Million
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $2.76 Million - $3.71 Million	171,883 Added 5.18%	3,487,753 $65.2 Million
Q1 2023 May 15, 2023	SELL	$17.19 - $30.8 $842,602 - $1.51 Million	-49,017 Reduced 1.46%	3,315,870 $60.8 Million

Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $4.64 Million - $7.01 Million	285,145 Added 9.26%	3,364,887 $66.6 Million
Q3 2022 Nov 14, 2022	SELL	$17.96 - $30.46 $22.5 Million - $38.2 Million	-1,254,941 Reduced 28.95%	3,079,742 $74.1 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $23.59 $3.69 Million - $8.49 Million	359,978 Added 9.06%	4,334,683 $79.1 Million
Q1 2022 May 16, 2022	BUY	$17.02 - $40.22 $459,880 - $1.09 Million	27,020 Added 0.68%	3,974,705 $87.4 Million
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $1.34 Million - $1.8 Million	45,507 Added 1.17%	3,947,685 $145 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $9.22 Million - $12.2 Million	308,779 Added 8.59%	3,902,178 $121 Million
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $18.2 Million - $40.6 Million	1,013,553 Added 39.29%	3,593,399 $114 Million
Q1 2021 May 17, 2021	SELL	$16.0 - $24.46 $90,208 - $137,905	-5,638 Reduced 0.22%	2,579,846 $57.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $41.1 Million - $106 Million	2,585,484 New	2,585,484 $51.1 Million

Others Institutions Holding RAPT

# of Institutions

148

Shares Held

29.2M

Call Options Held

709K

Put Options Held

1.06M

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $119M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Rapt Therapeutics, Inc. Transaction History